NORTHAMPTON, MA / ACCESS Newswire / November 18, 2025 / SLR - A new investor-led report calls on global pharmaceutical ...
Fintel reports that on November 18, 2025, Guggenheim maintained coverage of Centessa Pharmaceuticals plc - Depositary Receipt ...
Discover why Recursion Pharmaceuticals, Inc. stands out in AI drug discovery, but faces valuation risks. Click for my look at ...
Achieving proper drug dosages , particularly for pediatric patients, has been a pivotal point of research in pharmacology.
In September 2025, the European Commission (EC), together with the Heads of Medicines Agencies (HMA) and the European ...
West Pharmaceutical Services, Inc. ( WST) Jefferies London Healthcare Conference 2025 November 18, 2025 5:00 AM EST ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...
The "Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025" report has been added to ResearchAndMarkets.com's offering.Fully revised and updated, the report provides details of ...
No one is tracking the total number of animals used across U.S. labs.
Fintel reports that on November 17, 2025, D. Boral Capital maintained coverage of NRx Pharmaceuticals (NasdaqCM:NRXP) with a ...
Since May, the Trump administration has used tariffs and Most Favored Nation (MFN) drug pricing threats as a means to pressure ...